Billi, Saira E.

HRN: 11-14-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/04/2025
08/05/2025
IVT
500mg
Q8
S/P LTCS With BTL
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: